Partner Hospitals

Founded in 1956, it is a Grade A tertiary general hospital with orthopedics and burn medicine as key disciplines. Annual outpatient and emergency visits reach 3.0053 million, surgeries 90,400, and inpatient admissions 100,500. As the National Orthopedic Center, the hospital was the designated medical support hospital for the 2008 Beijing Olympic Games, the 2022 Beijing Winter Olympic Games and Winter Paralympic Games.

Founded in 1997, it is one of China’s leading private hospital groups. It has established 11 hospitals and 14 clinics in Hong Kong, Beijing, Shanghai, Guangzhou, Shenzhen, Tianjin, Qingdao and other cities. The annual number of patients served exceeds one million, including nearly 100,000 foreign patients. It has built a sizable international medical service network and formed a tiered medical service system of “general hospitals + specialized medical centers + clinics”. It covers a complete medical service chain including family medicine, emergency medicine, women’s health, pediatrics, cardiovascular and cerebrovascular diseases, oncology, urology, gastroenterology, orthopedics, critical care medicine and neuroscience center.

Founded in 1904. The hospital registers more than 5.3 million annual outpatient and emergency visits, over 180,000 annual inpatient admissions, and more than 120,000 annual inpatient operations. The leading specialties including Orthopedics and Endocrinology and Metabolism enjoy nationally top-tier medical capabilities. The cure rates for complex trauma, hand and foot microsurgery, and refractory endocrine diseases rank among the highest in China.

Founded in 1920. It is the supporting institution for the National Center for Stomatology and the National Clinical Research Center for Oral Diseases. Its Department of Plastic and Reconstructive Surgery remains the world’s largest plastic surgery medical center and China’s leading center for plastic surgery in medical treatment, teaching and research. Annual outpatient and emergency visits exceed 4.8 million, inpatient admissions over 150,000, inpatient surgeries more than 90,000, and outpatient surgical procedures over 170,000.

Founded in 1869, the hospital has set national benchmarks including the “Hangzhou Protocol” for transcatheter heart valve replacement, minimally invasive complex cataract surgery, standardized diagnosis and treatment of colorectal tumors, and mass severe trauma rescue. The perioperative survival rate of pediatric liver transplantation is at the internationally leading level.

Founded in 1947, it enjoys a high reputation in organ transplantation, infectious diseases, hematological diseases, kidney diseases, urinary system diseases and clinical pharmacy. It is one of China’s medical centers with the most complete range of large organ transplantation procedures.

Founded in 1964, it is a benchmark for cancer diagnosis and treatment in South China. Annual outpatient and emergency visits reach 2.558 million, and annual inpatient admissions are 222,000. Its medical volume ranks among the top of national oncology-specialized hospitals. It boasts leading medical technologies and an Asia-class radiotherapy center with top-tier hardware and software. Minimally invasive robotic surgeries are performed in multiple specialties. The hospital maintains cooperation with The University of Texas MD Anderson Cancer Center, which ranks No.1 among oncology centers in the United States.

Founded in 1892, it has reached leading domestic and international standards in many fields, such as adult living donor liver transplantation, early diagnosis and treatment of lung cancer, cardiac interventional therapy, neurosurgery and functional neurosurgery, integrated traditional Chinese and Western medicine for severe pancreatitis, and allogeneic combined larynx-trachea-thyroid transplantation.